Theresa Pattery, MD, PhD., is the Disease Management Programs Leader within R&D at Johnson & Johnson Global Public Health, focusing on the development and implementation of innovative, sustainable, integrated healthcare solutions for infectious diseases like TB & HIV, that are significantly impacting resource-limited countries and emerging markets. Driven by her patient-centric insight and commitment to end TB & HIV during her lifetime, she is working on accessible, affordable, mobile digital health solutions (medications, diagnostics & services) to facilitate access to patient care, via their cell phone, leveraging a simple tool that can improve health outcomes. She achieves this by establishing internal & external partnerships with key stakeholders, institutions, NGOs & funding organizations by working side-by-side with the different healthcare stakeholders, based on partnerships of trust and transparency.
Previously, Theresa was part of Janssen Diagnostics (J&J), within Medical Affairs as the US (CAP, CLIA, NY State & other US State Licenses) & EU-certified Laboratory & Medical Director for the accredited, clinical diagnostic laboratories in infectious diseases & oncology, providing services to multiple pharmaceutical companies in HIV, HCV & Oncology. In addition, she led the co-development of Idylla™ Ebola virus triage test with Biocartis N.V., that was granted emergency use authorization by US FDA and ensured that the Idylla™ Respiratory (IFV-RSV) panel received US FDA 510(k) clearance. She is also a trained & certified CAP (College of American Pathologists) Inspector & is responsible for the medical safety needs of Disease Management Programs at Global Public Health.
She is a Registered Medical Practitioner from the UK, specialized in Viral & Microbial Molecular Genetics from the Free University of Brussels (VUB) and is working at J&J in Belgium for the last 16 years.